It's not late to buyThe 55-day moving average broke down, just the 99-day moving average has remained to lift off.
with the positive result of the COVID-19 vaccine trial, everything is possible.
TNXP trade ideas
TONIX Pharma - Not a one trick pony....From what I hear this company has a ton of potential with lots of products and is not just a typical penny stock. Do your own research this is not financial advice.
Nice descending triangle break but lets watch and see if its time to go up.
TNXP FORECAST - TONIX PHARM HLDG CORPLong was triggered today with a 'boop' to the green line. Chances are it'll come back down below giving second chance to get long. Stop below white line, targets above green. THIS IS NOT FINANCIAL ADVICE. THIS IS RECORD KEEPING ONLY. DO NOT BLINDLY FOLLOW MY TRADES.
TNXP I think the target will be 2.2$TNXP is uptrend above MOV50
RSI > 40
MACD will cross
CMF > 0
I think the target will be 2.2
$TNXP Short Term Profit PossibleRSI shows oversold signal, with a bullish crossover. Uptrend is supported by all the MAs with no entanglement. Shooting STAR is present after a series of red candles. Cup and handle forming on the chart. Suggested buy point reflected on the chart as well. Chart was laid also with blue line for entry, green line for TPs and red for cutloss. Quick bucks possible on this one!
TNXP Harmonics: Target PracticeAfter gaining a sweet entry at the turn, I'll be shooting fish in a barrel with this bat harmonic. Check it out and load or reload around here!
TNXP Harmonics: Re-entry FishingBe aware that there may a different turning point here! We usually stick with it until the turn, so we can capitalize when it does turn. Check it out and load up!
TNXP Harmonics: Target PracticeShooting fish in a barrel over here with these bullish-butterfly take-profit targets. Check it out and load up!
Who is ready for fireworkInstitutions added ✅
Insider bought more shares ✅
Bullish chart set up ✅
All we need now is a news to start the trigger.
Short term target 4$+
Long term 8$+
TNXP: Bullish Pennant, confirmedBullish Pennant, confirmed.
Pros:
Descending volume during formation
Volume increase at break out
Golden cross in blue
PPS above 50MA and 200MA
RS above 0, but descending
ATR Ascending
R/R ratio above 4
200MA ascending
Cons:
250RSI below 50
PT = 2.65$
***TNXP BULLISH***TNXP
Opened a position (1.60$)
Expect it to follow the uptrend
Short term target (2,15$)
Risk: Tight stop loss
I'll close half position at target because of more upside potential.
( You can also put S/L higher )
AFTER NEW RUN, IT MIGHT CORRECT TO THESE LEVELS.
THIS GIVES US AN EXTRA BUY OPPORTUNITY FOR THE LONG RUN
DISCLAIMER:
NOT FINANCIAL ADVICE. MY OPINION/IDEA
$TNXPTonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, manufacturing, and licensing small molecules and biologics to treat and prevent human diseases and alleviate suffering. Its immunology product candidates include vaccines to prevent infectious diseases and biologics to address immunosuppression, cancer, and autoimmune diseases; and central nervous system (CNS) product candidates comprise small molecules and biologics to treat pain, neurologic, psychiatric, and addiction conditions. The company's lead vaccine candidate is TNX-1800, a live replicating vaccine based on the horsepox viral vector platform to protect against COVID-19. Its vaccines also comprise TNX-801, a live horsepox virus vaccine to protect against smallpox and monkeypox and serves as the vector platform; and TNX-2300 and TNX-2600, which are live replicating attenuated vaccine candidates for the prevention of COVID-19. In addition, the company's lead CNS candidate is TNX-102 SL, a sublingual formulation of cyclobenzaprine, which is in Phase 3 development for fibromyalgia, as well as in Phase 2 studies for agitation in Alzheimer's disease and alcohol use disorder. Further, its products include TNX-1300, which is in Phase 2 development for the treatment of life-threatening cocaine intoxication; TNX-601 CR for depression; and TNX-1900 for migraine and cranio-facial pain treatment. Additionally, its preclinical pipeline includes TNX-1600 for posttraumatic stress disorder, depression, and attention deficit hyperactivity disorder; TNX-701 for radioprotection; TNX-1200, a smallpox vaccine; TNX-1500 for transplant organ rejection and autoimmune conditions; and TNX-1700 for gastric and pancreatic cancers. The company is headquartered in Chatham, New Jersey.
TNXP short termBased on technical analysis and recent news about the company we can see a push towards 3$ in the short term.
i like it to $1.70 short term i think we can see more outa this i like it to $1.70 holding overnight for continuation
Tonix Pharmaceuticals LONGTERM FORECAST Weekly chart outlook for the long term. I see some upside in the near future . Lets see how this plays out. Mainly publishing to come back and study the price action.
Cup and Handle, ready to pop?Seeing cup and handle in the 1h chart.
Many catalyst brewing.
Going to pop soon, imo.
